Open AccessDoes Changing Antiretroviral Therapy in the First Trimester of Pregnancy for Safety Concerns Have an Impact on Viral Suppression?
Author(s) -
Violaine Peyronnet,
Josiane Warszawski,
Jeanne Sibiude,
Olivia Dialla,
Agnès Bourgeois-Moine,
E. Bui,
Caroline Simon Toulza,
Delphine Peretti,
Cécile Brunet-Cartier,
Véronique Avettand-Fènoël,
Jérôme Le Chenadec,
Albert Faye,
Roland Tubiana,
Laurent Mandelbrot
Publication year - 2019
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000001954
Subject(s) - pregnancy , medicine , gestation , viral load , cohort , obstetrics , prospective cohort study , cohort study , antiretroviral therapy , logistic regression , pediatrics , human immunodeficiency virus (hiv) , immunology , genetics , biology
To determine whether changing antiretroviral therapy (ART) during pregnancy because of concern about fetal risks led to poorer virological outcomes.